【Product Category】
The fourth generation quinolone antibacterial drugs
【Indications】
This product is indicated for the treatment of the following infections caused bysusceptible bacteria:
(1)Secondary infection of chronic respiratory disease, such as chronic bronchitis,diffuse panbronchiolitis, bronchiectasis, emphysema, pulmonary interstitial fibrosis, bronchial asthma, obsolete pulmonary tuberculosis, pneumonia, lung abscess, etc.
(2)Pyelonephritis, complicated urocystitis, prostatitis;
(3)Burn wound infection, surgical wound infection;
(4) Cholecystitis, cholangitis, hepatic abscess;
(5)Intra-abdominal abscess, peritonitis;
(6)Genital infection, such as adnexitis and endometritis; pelvic inflammatory disease.
【Dosage and Administration】
Administration: intravenous drip; dilute with 100mL of 0.9% saline or 5% glucose injection before use.
Dosage: twice a day, 0.3g each time; intravenous drip for 30 to 60 minutes and the course of treatment for 7 to 14 days.
The dosage can be adjusted according to the age and condition of patients, as appropriate. More details on the specification in the package insert.
【Strength】0.3g